Published in Obesity and Diabetes Week, June 21st, 2004
In a presentation entitled, "Oleoyl Estrone at Therapeutic Doses: Lack of Endocrine Histopathology in a Two Week, Oral Toxicity Trial in Rats," Manhattan scientists described positive results regarding Oleoyl estrone's safety profile following oral administration to adult rats of both genders. Safety observations were made over a 14 day period, including mortality, gross toxicity, blood, urine and carcass chemistries, blood and urine cellular counts, organ weights and histology.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.